Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Other Operating Expenses: 2011-2023

Historic Other Operating Expenses for Abeona Therapeutics (ABEO) over the last 12 years, with Dec 2023 value amounting to $540,000.

  • Abeona Therapeutics' Other Operating Expenses was N/A to $488,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $540,000 for FY2023, which is 91.16% down from last year.
  • According to the latest figures from FY2023, Abeona Therapeutics' Other Operating Expenses is $540,000, which was down 91.16% from $6.1 million recorded in FY2022.
  • In the past 5 years, Abeona Therapeutics' Other Operating Expenses ranged from a high of $37.5 million in FY2020 and a low of $540,000 during FY2023.
  • Moreover, its 3-year median value for Other Operating Expenses was $6.1 million (2022), whereas its average is $13.0 million.
  • Data for Abeona Therapeutics' Other Operating Expenses shows a maximum YoY slumped of 91.16% (in 2023) over the last 5 years.
  • Abeona Therapeutics' Other Operating Expenses (Yearly) stood at $37.5 million in 2020, then fell by 13.43% to $32.5 million in 2021, then crashed by 81.19% to $6.1 million in 2022, then crashed by 91.16% to $540,000 in 2023.